Diseases in Veterinary Medicine
A complete academic guide to animal disease — from infectious, parasitic, metabolic, and genetic conditions across companion animals, livestock, and exotic species, through diagnostic methods, treatment principles, zoonotic disease, antimicrobial resistance, and the One Health framework that connects animal health to human and environmental health.
Every veterinary student encounters the same moment early in their training: the realisation that the animals they will treat carry diseases that textbook medicine barely scratches. A dairy herd with subclinical mastitis across thirty percent of cows. A dog presenting with what looks like canine distemper but lives in a geography where it should be vaccinated. An imported reptile with cryptosporidiosis that may also be shedding Salmonella to its owner. Diseases in veterinary medicine are not simply a catalogue of pathogens and their hosts — they are a system of relationships between microorganisms, animal physiology, human practice, and environmental conditions that determine which animals get sick, how severely, and with what consequences for other animals and people.
This guide provides a comprehensive academic treatment of veterinary disease — its categories, mechanisms, species-specific manifestations, diagnostic approaches, and the broader frameworks (One Health, antimicrobial stewardship, disease surveillance) that give individual disease knowledge its clinical and public health context. Whether you are writing a veterinary pathology essay, preparing for a comparative anatomy or pharmacology examination, or producing a research paper on zoonotic disease control, the material here covers the conceptual and factual territory you need.
Disease Classification in Veterinary Medicine: A Framework for Understanding Animal Illness
Disease classification in veterinary medicine serves the same purpose as in human medicine: it organises the causes, mechanisms, and manifestations of illness into frameworks that guide diagnosis and treatment. Veterinary disease taxonomy draws on pathology, microbiology, physiology, genetics, and epidemiology — and because veterinary medicine spans dozens of species across wildly different physiologies and ecologies, classification must be flexible enough to accommodate a pig and a parrot, a thoroughbred and a tortoise, within the same conceptual structure.
Understanding this classification does not mean diseases fall neatly into single categories. Bovine respiratory disease complex — the single largest cause of economic loss in beef cattle production — involves viral pathogens (BHV-1, BVDV, BRSV, PI-3), secondary bacterial pathogens (Mannheimia haemolytica, Pasteurella multocida), stress-related immunosuppression (transport, weaning, commingling), and nutritional status. It is simultaneously infectious, metabolic, and environmental in its determinants. Effective veterinary disease management requires holding this multifactorial complexity rather than reducing it to a single causal category.
Infectious Diseases in Animals: Bacterial, Viral, Fungal, and Prion Pathogens
Infectious diseases are the largest and most clinically diverse category in veterinary medicine. They are caused by four fundamentally different types of pathogen, each with distinct biology, transmission characteristics, and therapeutic vulnerability. Understanding the basic biology of each pathogen class is prerequisite to understanding how the diseases they cause behave and how they respond — or fail to respond — to treatment.
Prokaryotic, unicellular organisms capable of independent reproduction
Bacterial veterinary pathogens include both Gram-positive (Staphylococcus, Streptococcus, Clostridium, Bacillus anthracis) and Gram-negative (Salmonella, E. coli, Pasteurella, Brucella, Leptospira) species. Some are obligate intracellular bacteria (Brucella, Mycobacterium, Coxiella burnetii) that survive and replicate inside host cells, complicating antibiotic penetration. Bacterial diseases are principally treatable with antibiotics, though antimicrobial resistance increasingly limits therapeutic options. Culture and sensitivity testing is critical for appropriate antibiotic selection in companion animal and livestock practice.
Obligate intracellular particles requiring host cell machinery to replicate
Viruses cause the majority of the most clinically severe and economically significant animal diseases. They are classified by nucleic acid type (DNA or RNA), capsid symmetry, and envelope status. RNA viruses (influenza, FMD virus, canine parvovirus, canine distemper) mutate at high rates, complicating vaccine development and producing antigenic variation. DNA viruses (herpesviruses, poxviruses, adenoviruses) are generally more genetically stable. Specific antiviral drugs exist for few veterinary viral diseases; treatment is primarily supportive. Prevention through vaccination is the cornerstone of viral disease control in veterinary medicine.
Eukaryotic organisms causing superficial and deep systemic mycoses
Fungal diseases in veterinary medicine range from superficial dermatophytoses (ringworm — Microsporum canis, Trichophyton species) to life-threatening systemic mycoses (Aspergillosis, Cryptococcosis, Histoplasmosis, Coccidioidomycosis). Systemic fungal infections most commonly affect immunocompromised animals but some organisms (Cryptococcus gattii, Coccidioides immitis) infect immunocompetent hosts. Antifungal treatment — azoles (itraconazole, fluconazole), polyenes (amphotericin B), or echinocandins — is prolonged, often months, and expensive. Aspergillus fumigatus causes severe sino-nasal disease in dogs and systemic aspergillosis in German Shepherd Dogs specifically, reflecting a breed-associated immune defect.
Transmissible spongiform encephalopathies caused by misfolded proteins
Prions are infectious misfolded proteins (PrPSc) that induce normal cellular prion proteins (PrPC) to adopt the same aberrant conformation. They cause progressive, fatal neurodegenerative diseases — transmissible spongiform encephalopathies (TSEs). Veterinary TSEs include Bovine Spongiform Encephalopathy (BSE/mad cow disease), Scrapie in sheep and goats, Chronic Wasting Disease (CWD) in cervids, and Feline Spongiform Encephalopathy (FSE). All are untreatable, invariably fatal, and of variable zoonotic potential — BSE caused the variant Creutzfeldt-Jakob Disease (vCJD) epidemic in humans in the 1990s–2000s, linked to consumption of contaminated beef products.
Key Diseases of Companion Animals: Dogs, Cats, and Small Mammals
Companion animal medicine — centred on dogs and cats but increasingly encompassing rabbits, guinea pigs, ferrets, rats, and birds — addresses a disease spectrum shaped by domestication, artificial breeding, vaccination programmes, and the close human-animal bond that drives owners to seek preventive and curative care. The major infectious diseases of dogs and cats have been transformed by vaccination, making clinical presentations of canine distemper or feline panleukopenia relatively uncommon in vaccinated populations but devastating when they occur in unvaccinated individuals or shelters.
Canine Parvovirus — The Most Clinically Significant Unvaccinated Dog Disease
Canine parvovirus type 2 (CPV-2), first identified in 1978, emerged from a mutation in feline panleukopenia virus and spread globally within two years — one of the fastest pandemic spreads of any animal pathogen on record. CPV-2 targets rapidly dividing cells: the intestinal crypt epithelium (causing haemorrhagic gastroenteritis with profuse, bloody diarrhoea), the bone marrow (causing profound leucopenia that removes the immune defence against secondary bacterial infection), and the myocardium in neonates (causing sudden death from myocarditis). Case fatality rates in unvaccinated, untreated puppies can reach 80–90%. With intensive supportive care — IV fluid therapy, antiemetics, antibiotics for secondary bacteraemia, nutritional support — survival rates in treated animals reach 85–95%. The virus is extraordinarily environmentally stable, surviving on surfaces for months to years; bleach (1:32 dilution) is the only readily available disinfectant reliably effective against it. Variants CPV-2a, CPV-2b, and CPV-2c have emerged since the original strain, with CPV-2c now predominating globally and requiring verification that current vaccines provide cross-protective immunity — which evidence suggests they do.
For students writing clinical case reports, disease review essays, or pharmacology assignments involving parvoviral treatment protocols, our nursing and health sciences case study writing service provides expert academic writing support.
Feline Infectious Peritonitis (FIP)
FIP is caused by a mutant form of the near-ubiquitous feline enteric coronavirus (FECV). In most cats, FECV causes mild or subclinical gastrointestinal infection. In a subset — typically young, immunocompromised, or genetically predisposed individuals — the virus mutates within macrophages to produce a virulent biotype (FIPV) capable of causing vasculitis and granulomatous inflammation. FIP presents in effusive (wet) form with fluid accumulation in body cavities, or non-effusive (dry) form with granulomatous lesions in organs. It was until recently invariably fatal. The antiviral drug GS-441524 (a nucleoside analogue) and its prodrug remdesivir have transformed FIP from a universally fatal diagnosis to a treatable disease, with remission rates exceeding 85% in clinical studies — one of the most dramatic therapeutic advances in small animal medicine in recent decades.
Canine Distemper
Canine distemper virus (CDV) — a morbillivirus related to measles virus — causes a multisystemic disease affecting respiratory, gastrointestinal, and neurological systems. Clinical signs progress from respiratory signs (nasal discharge, coughing) and gastrointestinal signs (vomiting, diarrhoea) to neurological signs (seizures, myoclonus, paresis, dementia) as the virus invades the CNS. The characteristic “hard pad disease” — hyperkeratosis of the footpads and nose — is pathognomonic in advanced cases. Case fatality is high; surviving dogs may suffer permanent neurological sequelae. Wildlife strains of CDV infect lions, leopards, seals, and other carnivores, making distemper a significant conservation concern beyond companion animal medicine.
Leptospirosis
Leptospirosis — caused by pathogenic serovars of Leptospira interrogans — is a bacterial infection of dogs (and rarely cats) with major zoonotic significance. Infection occurs through contact with water or soil contaminated with the urine of reservoir hosts (rats, hedgehogs, cattle, pigs). Clinical syndromes include acute renal failure (icterohaemorrhagiae serovar), hepatic failure, pulmonary haemorrhage syndrome (Pomona serovar), and haemolytic anaemia. Diagnosis is by paired MAT (microscopic agglutination test) titres or PCR of urine/blood. Treatment with doxycycline or penicillin (early), supportive care for organ failure. The zoonotic risk to dog owners and veterinary staff requires biosafety precautions during diagnosis and treatment.
Feline Immunodeficiency Virus (FIV)
FIV is a lentivirus (related to HIV) that infects CD4+ T lymphocytes, progressively depleting the immune system and predisposing cats to opportunistic infections. Transmission is primarily through deep bite wounds — outdoor, unneutered males are disproportionately affected. After initial viraemia, most cats enter an asymptomatic carrier phase lasting years before immunosuppression becomes clinically apparent. FIV-positive cats can live normal, healthy lives for extended periods with appropriate management, including keeping them indoors (reducing secondary infection risk and preventing transmission to other cats). There is no curative treatment; management focuses on monitoring, nutritional support, and prompt treatment of secondary infections.
Canine Lymphoma
Lymphoma is the most common haematopoietic malignancy in dogs, accounting for 7–24% of all canine cancers. The multicentric form — affecting multiple lymph node groups simultaneously — is most frequent. Diagnosis is by cytology or histopathology of affected lymph nodes. Chemotherapy protocols modelled on human CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone) produce remission in 65–90% of cases, with median survival of 12–13 months with treatment versus 4–6 weeks without. Golden Retrievers, Boxers, Scottish Terriers, Bulldogs, and Basset Hounds have disproportionate lymphoma incidence — breed-associated genetic predisposition is an active research area with implications for understanding lymphoma genetics in both dogs and humans.
Atopic Dermatitis in Dogs
Canine atopic dermatitis (CAD) is a chronic, pruritic inflammatory skin disease associated with IgE-mediated hypersensitivity to environmental allergens (dust mites, pollens, moulds). It affects an estimated 10–15% of the dog population and is among the most common reasons for veterinary dermatology referral. Clinical signs include pruritus (especially facial and pedal), recurrent otitis externa, and secondary pyoderma from self-trauma. Management involves allergen identification (intradermal testing or serology), allergen-specific immunotherapy (the only disease-modifying treatment), and symptomatic control with oclacitinib (Apoquel) — a JAK inhibitor — or lokivetmab (Cytopoint) — a monoclonal antibody targeting IL-31 — representing the most significant advances in veterinary dermatology pharmacology in decades.
Diabetes Mellitus in Cats and Dogs
Diabetes mellitus in cats is predominantly Type 2 (insulin resistance + progressive beta-cell failure), paralleling human Type 2 diabetes — obesity is the primary risk factor. In dogs, it is predominantly Type 1 (immune-mediated beta-cell destruction), requiring lifelong insulin supplementation. Diabetic cats — particularly those newly diagnosed — may achieve diabetic remission with early aggressive insulin therapy and dietary management, particularly with low-carbohydrate, high-protein diets. Dogs rarely achieve remission. Concurrent diseases (pancreatitis, hyperadrenocorticism in dogs, chronic kidney disease in cats) complicate management. The Burmese cat breed has significantly elevated genetic susceptibility to diabetes mellitus compared to other cat breeds.
Epilepsy in Dogs
Idiopathic epilepsy (genetic epilepsy without identifiable structural or metabolic cause) affects 0.6–0.75% of the dog population and is the most common chronic neurological disease in dogs. Breed predisposition is strong — Border Collies, Labrador Retrievers, Golden Retrievers, Belgian Shepherds, and others have markedly elevated prevalence. Treatment is with anti-epileptic drugs: phenobarbital and potassium bromide are first-line; imepitoin, levetiracetam, and zonisamide are used as adjuncts or alternatives. The International Veterinary Epilepsy Task Force has published consensus guidelines establishing diagnostic criteria, treatment initiation thresholds, and monitoring protocols — providing the evidence-based framework for epilepsy management in veterinary neurology.
Major Diseases of Livestock: Production Medicine and Herd-Level Disease
Livestock disease management operates at a fundamentally different scale from companion animal practice. The unit of concern is often the herd or flock rather than the individual animal — disease decisions involve economic thresholds, production impacts, and population-level epidemiology rather than individual clinical outcomes. The most significant livestock diseases combine clinical severity with economic impact through mortality, production loss, treatment costs, and trade restrictions that can devastate national agricultural industries following an outbreak.
Foot-and-Mouth Disease (FMD) — The World’s Most Economically Significant Animal Disease
FMD is caused by an Aphthovirus with seven distinct serotypes (O, A, C, SAT1, SAT2, SAT3, Asia1), each requiring serotype-specific vaccine coverage. It affects all cloven-hoofed animals — cattle, pigs, sheep, goats, and wild artiodactyls — causing vesicular lesions on the mouth, feet, and teats, resulting in lameness, reduced feed intake, weight loss, and in dairy cattle, dramatic milk production drops. Mortality in adults is low (1–5%) but significantly higher in young animals. The 2001 UK outbreak — spread by infected pigs transported while subclinically infected — resulted in the slaughter of over 6 million animals and economic losses estimated at £8 billion. FMD-free status, maintained through surveillance and vaccination-free zones, is the prerequisite for premium international livestock trade. The disease is controlled by the World Organisation for Animal Health (WOAH, formerly OIE) and is listed on WOAH’s List of Notifiable Terrestrial Animal Diseases.
African Swine Fever (ASF) — The Ongoing Global Emergency
African Swine Fever virus (ASFV), a unique large DNA virus with no vaccine licensed for routine commercial use as of mid-2025, causes a haemorrhagic fever in domestic pigs and wild boar with mortality approaching 100% in naive populations. The disease, endemic in sub-Saharan Africa and Sardinia for decades, spread through Eastern Europe from 2014 and into Asia in 2018 — reaching China, which holds approximately 50% of the world’s domestic pig population. The subsequent epidemic eliminated an estimated 25% of the world’s domestic pig herd between 2018 and 2020, causing global pork supply shortages and price increases. No licensed commercial vaccine with broad efficacy across circulating strains exists, making control dependent on strict biosecurity, early detection, culling, and movement restrictions. The ASF epidemic is the most severe animal disease outbreak in recorded history by number of animals affected.
Bovine Respiratory Disease Complex (BRDC)
BRDC — often called “shipping fever” in North America — is the most economically significant disease of beef cattle in feedlot production and the most common disease of cattle overall in temperate livestock systems. It is a multifactorial disease complex involving primary viral infection (BHV-1, BVDV, BRSV, PI-3), secondary bacterial infection (Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, Mycoplasma bovis), and predisposing stressors (transport, weaning, commingling, temperature stress). Stress activates the hypothalamic-pituitary-adrenal axis, suppressing immune function and allowing bacterial proliferation in the respiratory tract following viral damage to mucosal defences. BRDC costs the US beef industry alone an estimated $800–900 million per year in cattle deaths, treatment costs, and reduced performance. Metaphylaxis — treating all animals in a high-risk group with long-acting antimicrobials at arrival — is widely used in North American feedlots but raises antimicrobial stewardship concerns.
Bovine Mastitis — The Most Costly Disease in the Dairy Industry
Mastitis — inflammation of the mammary gland, overwhelmingly caused by bacterial infection — is the most frequently occurring and economically costly disease in dairy cattle worldwide. Direct costs include discarded milk, treatment costs, veterinary fees, and premature culling; indirect costs include reduced milk production, impaired reproductive performance, and increased herd-level somatic cell count (SCC) penalties from milk processors. Major pathogens include contagious bacteria (Staphylococcus aureus, Streptococcus agalactiae — spread cow-to-cow at milking) and environmental bacteria (E. coli, Klebsiella, environmental Streptococci — acquired from contaminated environments). Diagnosis is by bacteriological culture of milk samples with California Mastitis Test (CMT) as a rapid screening tool. Treatment — intramammary antibiotic tubes and systemic antibiotics for severe cases — must be guided by culture and sensitivity to avoid contributing to AMR. The European Medicines Agency’s restrictions on use of highest-priority critically important antibiotics in food animals directly affect mastitis treatment protocols in European dairy practice.
Highly Pathogenic Avian Influenza (HPAI) — The Zoonotic Pandemic Risk
Highly Pathogenic Avian Influenza (HPAI) viruses — particularly H5N1, H5N8, and H5N6 clades — cause rapid-onset, high-mortality disease in poultry with mortality approaching 100% in naive flocks within days of infection. Wild migratory waterfowl serve as the natural reservoir, showing minimal clinical signs while transmitting virus to domestic poultry through direct contact or contaminated water and fomites. HPAI outbreaks trigger mandatory culling of affected flocks, movement restrictions, and international poultry trade bans — producing enormous economic losses. The zoonotic dimension is of primary global health concern: H5N1 has caused over 460 confirmed human deaths with a case fatality rate of approximately 60% since 2003, raising longstanding pandemic preparedness concerns. H5N1 clade 2.3.4.4b, responsible for unprecedented global spread in 2021–2024, has demonstrated the capacity to infect mammals including seals, sea lions, foxes, and cattle — with confirmed human cases in US dairy workers in 2024 marking a new phase in the H5N1 epidemiology. The WHO and FAO monitor HPAI through the Global Early Warning System (GLEWS) as a One Health priority.
Annual economic cost of Bovine Respiratory Disease Complex to the US beef industry alone
BRDC is the single most economically significant disease in North American beef cattle production — accounting for more economic loss than any other single condition in feedlot systems. The multifactorial nature of the condition — requiring viral, bacterial, and stress-related management simultaneously — makes it resistant to simple control measures and continues to drive the majority of antibiotic use in US beef production.
Parasitic Diseases: Endoparasites, Ectoparasites, and Vector-Borne Disease
Parasitology in veterinary medicine encompasses an enormous diversity of organisms — from single-celled protozoa to metre-long tapeworms, from skin-burrowing mites to haematophagous ticks carrying multiple pathogens simultaneously. According to the World Organisation for Animal Health (WOAH) disease information system, parasitic diseases collectively represent one of the largest burdens on global livestock production and a significant source of companion animal morbidity in all regions. The economic and welfare impact of parasitic disease is chronically underestimated because many parasitic infections cause subclinical production losses rather than the visible, dramatic mortality associated with acute infectious disease outbreaks.
Gastrointestinal Helminths
Nematode parasites of the gastrointestinal tract are the most economically significant parasites of ruminants globally. In sheep and goats, Haemonchus contortus (the barber’s pole worm) causes haemorrhagic anaemia by feeding on blood from abomasal mucosa — sufficient adult worm burdens can kill a sheep within weeks. In cattle, Ostertagia ostertagi (brown stomach worm) damages the abomasal mucosa, disrupting protein digestion and producing hypoalbuminaemia, submandibular oedema, and reduced growth. In dogs and cats, Toxocara canis and Toxocara cati cause visceral larva migrans in humans — a zoonotic risk from soil contaminated with pet faeces. Anthelmintic resistance — particularly to benzimidazoles and macrocyclic lactones — is now so widespread in small ruminant nematodes that most veterinary parasitology guidelines recommend FECRT (faecal egg count reduction testing) to confirm efficacy before treatment in any new system.
Ectoparasites — Ticks, Mites, Fleas
Ectoparasites cause both direct harm (blood loss, skin damage, myiasis) and indirect harm as vectors for pathogens of far greater clinical significance than the parasites themselves. The tick Ixodes ricinus in Europe and Ixodes scapularis in North America transmit Borrelia burgdorferi (Lyme borreliosis), Anaplasma phagocytophilum, Babesia species, and tick-borne encephalitis virus. Rhipicephalus (Boophilus) microplus transmits Babesia bovis and Anaplasma marginale in tropical and subtropical cattle systems. Sarcoptes scabiei causes sarcoptic mange (scabies) in dogs and is transmissible to humans as a temporary infestation. The cat flea (Ctenocephalides felis) is the intermediate host for the tapeworm Dipylidium caninum and the vector for Bartonella henselae (cat scratch disease in humans).
Protozoan Parasites
Protozoal veterinary pathogens include coccidians (Eimeria species causing clinical coccidiosis in calves, lambs, and poultry; Toxoplasma gondii; Cryptosporidium parvum), apicomplexans (Babesia species causing tick-borne haemolytic anaemia; Theileria species causing East Coast Fever in African cattle — one of the most economically significant cattle diseases on the continent), trypanosomes (Trypanosoma brucei brucei causing nagana in African livestock; Trypanosoma congolense), and Leishmania species causing visceral and cutaneous leishmaniasis in dogs with zoonotic transmission via sandfly vectors in Mediterranean and tropical regions.
Resistance to anthelmintic drugs — benzimidazoles, macrocyclic lactones (ivermectin, doramectin, moxidectin), and levamisole — in gastrointestinal nematodes of sheep and goats is now present on every continent where these animals are farmed. In some regions (Australia, South Africa, Uruguay), multi-drug resistance — resistance to drugs from all three major anthelmintic classes simultaneously — is the norm rather than the exception in Haemonchus contortus populations. The result is that some sheep farmers have no reliably effective anthelmintic available.
Sustainable approaches to worm control — selective treatment (FAMACHA scoring to treat only anaemic individuals), refugia-based strategies (maintaining a proportion of untreated animals to dilute resistant worm populations with susceptible ones), genetic selection for host resistance, and biological control (Duddingtonia flagrans, a nematode-trapping fungus) — are replacing blanket prophylactic treatment protocols that drove resistance development. Students studying veterinary pharmacology or production medicine will encounter anthelmintic resistance as a central topic; our science research paper writing service supports writing in this area.
Metabolic and Nutritional Diseases: When Physiology and Diet Fail
Metabolic diseases arise when normal physiological processes are overwhelmed by the demands placed on an animal — most commonly in high-production contexts where genetic selection for productivity has outpaced the animal’s capacity for homeostatic regulation. Nutritional diseases result from dietary imbalances: deficiencies, excesses, or imbalances in specific nutrients that disrupt cellular function, organ development, or immune competence. Both categories disproportionately affect intensively managed livestock, though companion animals are increasingly affected by nutritional diseases associated with inappropriate commercial or home-prepared diets.
Neoplastic and Genetic Diseases: Cancer and Inherited Conditions in Animals
Neoplasia — the abnormal, uncontrolled proliferation of cells — is a major cause of morbidity and mortality in companion animals and is increasingly recognised in production animals and wildlife. Genetic and hereditary diseases, driven by the extreme selective pressures of artificial breeding in companion animals, constitute a significant proportion of morbidity in pedigree breeds. Both areas have expanded dramatically with advances in veterinary oncology and genetic testing technologies in the past two decades.
Dogs share more than 200 naturally occurring heritable diseases with humans — more than any other non-human animal — making them uniquely valuable models for understanding the genetics of both cancer and complex inherited conditions.
Elaine Ostrander, National Human Genome Research Institute — foundational framing for canine comparative genomics research
Cancer in companion animals is not simply a veterinary welfare problem — it is a comparative medicine opportunity. The spontaneous cancers in dogs are biologically more similar to human cancers than the induced laboratory mouse models we have used for decades.
Perspective from One Health oncology and comparative cancer biology research literature
Dogs Develop Cancer
Approximately one in four dogs will develop some form of cancer during their lifetime — a rate comparable to human cancer incidence
Deaths in Dogs Over 10
Cancer is estimated to cause approximately 50% of deaths in dogs over the age of 10 years — the leading cause of death in older companion dogs
Hereditary Conditions in Dogs
More than 600 genetic disorders have been identified in dogs, with DNA tests available for several hundred breed-specific mutations
Breed-Associated Genetic Disease — The Consequence of Selective Breeding
The extreme genetic bottlenecks created by the closed studbook breeding of pedigree dog and cat breeds have fixed disease-causing alleles in breed populations. Some of these are direct consequences of selecting for the physical characteristics that define a breed: brachycephalic airway obstruction syndrome (BAOS) in Bulldogs, French Bulldogs, Pugs, and Persian cats is an inevitable result of selecting for extreme skull shortening. Chondrodystrophy — the short-limbed body type of Dachshunds, Corgis, and Basset Hounds — produces intervertebral disc disease (IVDD) as a direct consequence of the same FGF4 retrogene insertion that causes the desired limb morphology. Hip dysplasia in German Shepherd Dogs and Labrador Retrievers results from polygenic susceptibility to hip joint malformation, exacerbated by rapid growth rates and body condition. Progressive retinal atrophies (PRAs) affect numerous breeds through different breed-specific mutations causing photoreceptor degeneration and eventual blindness.
Genetic screening — DNA tests for known breed-specific mutations, OFA (Orthopedic Foundation for Animals) hip and elbow scoring, CAER eye examinations — allows breeders to make informed selection decisions, reducing the prevalence of many heritable conditions over generations. However, selection against disease-causing alleles is complicated when those alleles are in linkage disequilibrium with desired traits, or when the causal variant affects fitness in complex polygenic ways that simple screening tests cannot capture.
Exotic Animal and Wildlife Disease: Species-Specific Considerations
Exotic animal medicine — encompassing reptiles, birds, fish, small mammals, and invertebrates kept as pets — requires substantial species-specific knowledge because disease presentations, husbandry-related disease, and pharmacological responses differ fundamentally from those of dogs and cats. Wildlife disease adds further complexity through conservation dimensions: the same disease that is a manageable welfare concern in a captive collection may be an existential threat to a wild population.
Reptile Medicine — Husbandry as the Primary Determinant of Disease
The majority of disease in captive reptiles is husbandry-related rather than primarily infectious: inappropriate temperature gradients (preventing proper thermoregulation and immune function), inadequate UVB provision (causing metabolic bone disease from vitamin D3 deficiency), incorrect humidity (causing dysecdysis — retained shed — in snakes and lizards), and inappropriate diet. Metabolic bone disease (MBD) — characterised by pathological fractures, skeletal deformities, and seizures from hypocalcaemia — is the most common presentation in captive lizards and tortoises on calcium-poor, vitamin D3-deficient diets. Viral diseases (inclusion body disease in boids, caused by arenaviruses; reptarenavirus and hartmanivirus), bacterial septicaemia (often Gram-negative — Salmonella, Pseudomonas, Aeromonas), and flagellate protozoa (Entamoeba invadens) are significant infectious concerns in reptile collections.
Avian Medicine — Psittacines and Poultry
Pet birds — particularly psittacines (parrots, cockatiels, budgerigars) — present with diseases ranging from psittacine beak and feather disease (PBFD, a circovirus causing immunosuppression and progressive feather loss) to proventricular dilatation disease (PDD, caused by avian bornavirus) to psittacosis (Chlamydia psittaci — an important zoonosis causing atypical pneumonia in humans). Aspergillosis is the most significant fungal disease of captive birds, particularly birds of prey, causing granulomatous air sacculitis and pneumonia in the respiratory tract. In poultry, Marek’s disease (herpesvirus), Newcastle disease (paramyxovirus), infectious bursal disease (Gumboro disease), and coccidiosis represent the most significant routine disease challenges in commercial production, all managed primarily through vaccination and biosecurity.
Wildlife Disease — Conservation and Spillover
Wildlife disease sits at the intersection of veterinary medicine, ecology, epidemiology, and conservation biology. Diseases that cause morbidity rather than mortality in reservoir hosts become devastating when spilling over into naive populations: Tasmanian Devil Facial Tumour Disease (DFTD) — a transmissible cancer spread by biting — has reduced the Tasmanian devil population by over 80% since its discovery in 1996 and represents one of only three known naturally occurring transmissible cancers. White-nose syndrome (Pseudogymnoascus destructans, a fungal pathogen) has killed over 6 million North American bats since its appearance in 2006, with population impacts as high as 99% in some species. Chronic Wasting Disease (CWD) in North American deer and elk continues to spread geographically with no effective control measure identified. Chytrid fungus (Batrachochytrium dendrobatidis and B. salamandrivorans) has driven over 90 amphibian species to extinction or near-extinction — the greatest recorded vertebrate biodiversity loss caused by a single infectious agent.
Diagnostic Methods in Veterinary Medicine: From Clinical Examination to Molecular Pathology
Veterinary diagnosis begins with the clinical examination and works outward through increasingly specialised diagnostic tools. The sequence — history, physical examination, differential diagnosis list, targeted diagnostic testing, diagnosis, treatment plan — is structurally identical across species, though the specific tools, normal reference ranges, and disease probabilities differ entirely between a cat, a cow, and a cockatoo.
History and Signalment
Species, breed, age, sex, reproductive status, vaccination history, diet, housing, travel history, contact with other animals, and owner-reported signs form the foundation of every veterinary diagnostic encounter. Signalment alone dramatically shapes the differential diagnosis list: a 1-year-old unvaccinated dog with haemorrhagic diarrhoea and leucopenia has parvovirus as the overwhelming probability; the same presentation in a 9-year-old vaccinated dog raises a different differential list entirely. In production animal medicine, the herd history — management system, nutrition programme, vaccination protocols, recent introductions — is as diagnostically important as the individual animal’s signalment.
Physical Examination and Clinical Pathology
Systematic physical examination — temperature, pulse, respiratory rate, mucous membrane colour and CRT, lymph node palpation, thoracic auscultation, abdominal palpation, neurological assessment — provides the clinical data set that directs further testing. Complete blood count (CBC) quantifies red cells, white cells (with differential), and platelets — identifying anaemia, leucopenia, leucocytosis, thrombocytopenia. Serum biochemistry panel evaluates organ function — hepatic enzymes (ALT, AST, GGT, ALP, bilirubin), renal parameters (creatinine, BUN/urea, SDMA), glucose, albumin, electrolytes, cholesterol. Urinalysis assesses renal concentrating ability, proteinuria, haematuria, and urinary tract infection. Together, CBC and biochemistry provide the first objective data layer above clinical observation.
Microbiology — Culture, Sensitivity, PCR
Bacterial culture of appropriate samples (blood, urine, cerebrospinal fluid, joint fluid, wound exudates, milk) identifies the causative organism and, through antimicrobial sensitivity testing (Kirby-Bauer disc diffusion or broth microdilution MIC testing), determines which antibiotics it remains sensitive to. PCR (polymerase chain reaction) amplifies pathogen-specific DNA or RNA sequences, enabling rapid identification of fastidious organisms that culture poorly, detection of pathogens at very low copy numbers, and simultaneous multi-pathogen panels. Real-time (quantitative) PCR provides numerical estimates of pathogen load. Metagenomic next-generation sequencing (mNGS) sequences all nucleic acids in a sample simultaneously, identifying any organism present without prior hypothesis — particularly useful in diagnosing novel or unexpected pathogens.
Serology and Immunodiagnostics
Serological tests detect either specific antibodies (indicating prior exposure or vaccination) or specific antigens (indicating active infection). The ELISA (enzyme-linked immunosorbent assay) is the workhorse of veterinary serology — used for FeLV antigen and FIV antibody testing in cats, Brucella antibody testing in cattle, Toxoplasma titres, Leishmania antibody detection, and many others. The AGID (agar gel immunodiffusion) test is the standard for equine infectious anaemia (Coggins test) and EIAV confirmation. Paired serology — testing acute and convalescent samples 2–3 weeks apart — demonstrates rising antibody titres indicating active infection rather than prior exposure or vaccination. Immunofluorescence (IFA, IFAT) is used for Leishmania, tick-borne organisms, and others.
Diagnostic Imaging
Radiography remains foundational in companion animal and equine practice — evaluating bone density and integrity, cardiac silhouette and pulmonary pattern, abdominal organ size and position, and intestinal gas patterns. Ultrasonography is essential for soft tissue evaluation — hepatic parenchyma, splenic masses, bladder wall, cardiac chambers and function (echocardiography), reproductive structures, and guided aspiration/biopsy of lesions. CT (computed tomography) provides three-dimensional imaging for complex anatomical assessment — nasal cavity disease, thoracic masses, skull fractures, spinal cord compression, and surgical planning. MRI is the gold standard for brain and spinal cord imaging. Point-of-care ultrasound (POCUS) — rapid focused assessment — is increasingly integrated into emergency triage protocols for haemoperitoneum, pleural effusion, and cardiac standstill assessment.
Histopathology and Cytology
Cytology — microscopic examination of cells from fine-needle aspirates, impression smears, or fluid samples — provides rapid, inexpensive preliminary assessment of masses and effusions, distinguishing inflammatory from neoplastic processes and identifying cell types. Histopathology — examination of formalin-fixed, paraffin-embedded tissue sections — provides definitive diagnosis of neoplasms (tumour type and grade), characterises inflammatory lesions (granulomatous versus suppurative versus lymphocytic), and identifies infectious agents in tissue. Post-mortem examination (necropsy) remains the most information-rich diagnostic event in veterinary medicine — particularly important in herd/flock disease investigation where index case necropsy guides management of remaining animals. Submission of properly collected and preserved samples to a diagnostic laboratory with experienced veterinary pathologists is critical for accurate histopathological diagnosis.
Parasitology Testing
Faecal examination — direct smear, flotation (using saturated salt or sugar solutions with specific gravities that float parasite eggs while sinking faecal debris), sedimentation (for fluke eggs that don’t float reliably) — identifies parasite eggs, larvae, oocysts, and cysts. Faecal egg count (McMaster technique, FECPAKG2 digital imaging systems) quantifies egg production to assess infection level and guide treatment decisions. Baermann technique concentrates motile larvae for lungworm diagnosis. Heartworm diagnosis in dogs uses antigen ELISA (detecting female worm antigen) combined with Knott’s test or filter concentration to detect circulating microfilariae. Skin scraping deep to the follicular level is required for Demodex mite diagnosis; superficial scraping is adequate for Sarcoptes detection.
Genetic and Genomic Testing
DNA-based genetic testing for heritable disease mutations is now routine in companion animal breeding practice. Breed-specific panels test for mutations causing progressive retinal atrophies, hereditary cataracts, hereditary nephropathy, exercise-induced collapse, multidrug resistance (MDR1/ABCB1 mutation in collies), degenerative myelopathy, and many others. Whole-genome sequencing of animals with novel inherited conditions enables identification of causal variants through genome-wide association studies (GWAS) in breed cohorts. In oncology, somatic mutation profiling of tumour tissue — identifying the specific driver mutations in an individual tumour — is guiding targeted therapy selection in canine mast cell tumours (c-KIT mutation, responsive to toceranib/Palladia) and other cancers.
Treatment Principles in Veterinary Medicine Across Species
Veterinary therapeutics is complicated by the species diversity of patients: a drug dose safe and effective in a dog may be lethal in a cat, ineffective in a horse, or economically impractical in a cow. The principles governing treatment decisions — efficacy, safety, withdrawal periods for food-producing animals, antimicrobial stewardship, and client-owner compliance — apply universally, but their application requires species-specific pharmacological knowledge that spans decades of comparative pharmacology research.
Every drug used in a food-producing animal has a withdrawal period (WP) — the minimum time that must elapse between the last treatment and slaughter for meat, or before milk can enter the food chain. Withdrawal periods are set by regulatory authorities (EMA in Europe, FDA in the USA) based on pharmacokinetic data ensuring drug residues fall below maximum residue limits (MRLs) in edible tissues by the end of the WP.
Using a drug off-label (at an unlicensed dose, by an unlicensed route, or in a species without a licensed product) requires veterinary judgement about extended withdrawal periods — the cascade principle in European veterinary medicine. Failure to observe withdrawal periods is a legal offence and a food safety risk. For production animal students and veterinarians, withdrawal period management is as fundamental a skill as diagnosis. Students studying food animal medicine or public health can access expert writing support through our public health assignment writing service.
Zoonotic Diseases: Where Animal Health Meets Public Health
Zoonotic diseases — infections transmissible between non-human animals and humans — represent the most direct link between veterinary medicine and human public health. The WHO estimates that 60% of known human infectious diseases are of animal origin, and that 75% of emerging infectious diseases affecting humans are zoonotic. COVID-19, likely of bat-coronavirus origin with potential intermediate hosts; HIV, derived from simian immunodeficiency viruses; Ebola, reservoir-linked to fruit bats; and influenza pandemics originating in avian and swine reservoirs all illustrate the recurrent pattern: pathogens in animal reservoirs acquire the capacity for human infection, and the consequences can be global.
Global burden of selected zoonotic diseases — scope and significance
Rabies
Caused by Rabies lyssavirus, transmitted through the saliva of infected mammals — predominantly dogs in developing world contexts (responsible for 95%+ of human rabies deaths globally). Once clinical signs appear, rabies is virtually 100% fatal in humans and animals. Post-exposure prophylaxis (PEP) — immediate wound washing, rabies immunoglobulin, and vaccine course — is nearly 100% effective if initiated before CNS invasion. Mass dog vaccination is the primary public health intervention for reducing human rabies mortality. Countries including the UK, Australia, Japan, and many island nations are rabies-free; travel from endemic regions is a biosecurity concern.
Brucellosis
Brucella abortus (cattle), B. melitensis (sheep, goats), and B. suis (pigs) cause reproductive failure in livestock and a febrile undulant fever syndrome in humans — typically through contact with infected animals, ingestion of unpasteurised dairy products, or laboratory exposure. Brucellosis causes more human disease globally than any other zoonosis except tuberculosis. Eradication programmes in developed countries (test-and-slaughter, vaccination) have eliminated or greatly reduced cattle brucellosis in much of Western Europe and North America. It remains endemic and a major public health concern across the Middle East, Mediterranean, Central Asia, and parts of Latin America.
Psittacosis (Chlamydiosis)
Chlamydia psittaci — an obligate intracellular bacterium — infects parrots, cockatiels, pigeons, and many wild bird species. Humans acquire infection through inhalation of dried faecal particles or respiratory secretions from infected birds, causing atypical pneumonia characterised by severe headache, myalgia, and dry cough — often misdiagnosed as Mycoplasma pneumonia. Veterinary professionals, pet shop workers, poultry farmers, and pigeon keepers are at elevated occupational risk. Treatment with doxycycline in both infected birds and humans. Notifiable to public health authorities in most jurisdictions.
Antimicrobial Resistance in Veterinary Medicine: The Shared Threat
Antimicrobial resistance (AMR) is among the most significant global health threats of the 21st century, and veterinary medicine is both a contributor to and a victim of it. The use of antibiotics in animal populations — for treatment, metaphylaxis, and historically for growth promotion — selects for resistant bacteria in animal populations. These resistant organisms, their resistance genes, and their conjugative resistance plasmids enter human populations through food, environmental contamination, and direct contact. The consequence is a shared resistance landscape across human and veterinary medicine that neither can address unilaterally.
Critically Important Antimicrobials (CIAs) in Veterinary Medicine
The WHO classifies antimicrobials by their importance for treating human infectious diseases — Critically Important Antimicrobials (CIAs) are those used as the last resort or sole treatment for serious human infections. Their use in animals is the most contentious area of veterinary-human AMR interface. The WHO CIA list relevant to veterinary medicine includes 3rd and 4th generation cephalosporins, fluoroquinolones, polymyxins (colistin), carbapenems, and glycopeptides (vancomycin).
The European Union’s Veterinary Medicinal Products Regulation (EU 2019/6), which came into force in January 2022, restricts the use of antibiotics reserved for human medicine in animals — a regulatory landmark that prohibits prophylactic use of CIAs in food-producing animals and bans colistin for routine animal growth promotion EU-wide. The UK’s VARSS (Veterinary Antibiotic Resistance and Sales Surveillance) report monitors antimicrobial sales and resistance in companion animals and food-producing species annually. Students studying public health, pharmacology, or food safety policy will find AMR in veterinary contexts a core topic; our public health assignment writing and scientific research paper writing services support assignments in this area.
The most clinically significant AMR problem in companion animal medicine is multidrug-resistant Staphylococcus pseudintermedius (MRSP) — the canine equivalent of MRSA — and methicillin-resistant Staphylococcus aureus (MRSA) infections in dogs and cats that can transmit between pets and their owners. Extended-spectrum beta-lactamase (ESBL)-producing E. coli and Klebsiella — resistant to all cephalosporins — are an increasing problem in urinary tract infections in companion animals.
The One Health Framework: Integrating Animal, Human, and Environmental Health
One Health is not merely a slogan — it is a working conceptual and institutional framework for addressing health problems that cannot be solved from within a single species or discipline. The framework was formalised through the quadripartite partnership of WHO, FAO, WOAH (formerly OIE), and UNEP in 2022 with the One Health Joint Plan of Action — a five-year programme addressing zoonotic diseases, AMR, food safety, and the health of ecosystems. Understanding the One Health framework is now a core competency in veterinary education in the UK, US, EU, and Australia.
Disease Emergence Through the One Health Lens
Most pandemic threats emerge from the wildlife-livestock-human interface. Land use change — deforestation, agricultural expansion, urbanisation — brings humans and domestic animals into contact with wildlife species harbouring novel pathogens. The emergence of Nipah virus (from fruit bats via pig farming in Malaysia), SARS-CoV-1 and SARS-CoV-2 (likely bat coronaviruses), Ebola (bat reservoir, primate amplification), and Hendra virus (fruit bats in Australia, horses as amplification hosts) all follow the same pattern: habitat disruption concentrating wildlife near human-domestic animal interfaces creates spillover opportunities that previously did not exist. Veterinary surveillance of wildlife and domestic animal populations is the earliest warning system for pathogen emergence — making veterinarians critical actors in pandemic prevention rather than peripheral participants in a human health problem.
AMR as a One Health Challenge
Antimicrobial resistance is the paradigm case for One Health intervention: resistant organisms and resistance genes move continuously between human clinical settings, animal populations, food-producing environments, waterways, and soil. Resistant E. coli from poultry production in Asia have been detected in wild migratory birds flying international routes. ESBL-producing bacteria from hospital sewage contaminate rivers that irrigate crops. The same mobile resistance elements (plasmids carrying NDM-1, OXA-48, and other carbapenemase genes) circulate in human, animal, and environmental bacterial populations simultaneously. Addressing AMR requires coordinated action across human medicine prescription practices, veterinary antimicrobial stewardship, agricultural policy, environmental monitoring, and international regulatory alignment — precisely the multi-sector integration that One Health provides.
Disease Prevention and Control Strategies in Veterinary Medicine
Prevention of animal disease is more cost-effective than treatment in nearly every context — from the economics of companion animal vaccination to the epidemiology of disease-free zone maintenance for international livestock trade. The spectrum of preventive tools available in veterinary medicine spans from molecular-level vaccine design through farm-level biosecurity to international disease surveillance and notification systems.
Vaccination — The Cornerstone of Infectious Disease Prevention
Veterinary vaccines span all major antigen delivery platforms: modified live virus vaccines (MLV), killed/inactivated vaccines, subunit vaccines, virus-like particles (VLPs), DNA vaccines (licensed for West Nile Virus in horses and melanoma in dogs), and mRNA vaccines (now in development for several veterinary pathogens following the COVID-19 platform proof-of-concept). Vaccination schedules — primary course, boosters, triennial revaccination for selected antigens — are guided by species-specific guidelines (WSAVA guidelines for dogs and cats; BVACCC for cattle). Vaccine failure can occur due to maternal antibody interference in young animals, incorrect cold chain storage, inappropriate administration route, or inadequate immune response in immunocompromised individuals. Titre testing (serology to measure vaccine-induced antibody levels) is increasingly used as an alternative to automatic booster vaccination in companion animals.
Biosecurity — Preventing Pathogen Introduction and Spread
Farm biosecurity — physical and procedural barriers preventing pathogen introduction to, or spread within, an animal population — is the primary disease-control tool for pathogens for which vaccines either don’t exist (ASF) or are inadequate (FMD during an outbreak). External biosecurity (bioexclusion) addresses pathogen introduction: access restriction, vehicle disinfection, quarantine of incoming animals, rodent and wildlife exclusion, controlled visitor access, and hygienic sourcing of feed and water. Internal biosecurity (biocontainment) limits spread within the farm if introduction occurs: all-in/all-out production flows, separate air spaces between production groups, age-segregated management, and rapid identification and isolation of sick animals. In companion animal settings, biosecurity principles apply in veterinary hospital infection control — isolating infectious cases, hand hygiene protocols, and disinfection of examination surfaces between patients.
Disease Surveillance and Early Warning Systems
Effective disease control depends on detecting outbreaks early enough for intervention to be effective. Passive surveillance — veterinary practitioners reporting notifiable diseases, laboratory submissions of diagnostic samples — is complemented by active surveillance: systematic sampling of defined populations, testing at slaughter, and sentinel herd programmes. The UK’s APHA (Animal and Plant Health Agency), USDA’s APHIS (Animal and Plant Health Inspection Service), and equivalent agencies in other countries maintain national surveillance infrastructure. WOAH’s WAHIS (World Animal Health Information System) provides real-time reporting of significant animal disease events globally — a critical tool for early warning of transboundary animal disease threats. FAO’s EMPRES (Emergency Prevention System for Transboundary Animal and Plant Pests and Diseases) focuses on early warning and rapid response for high-consequence diseases.
From Rinderpest to the Next Candidate
Rinderpest — “cattle plague,” a morbillivirus causing high-mortality haemorrhagic disease in cattle and buffalo — was declared globally eradicated in 2011 by FAO and WOAH: only the second animal disease eradicated worldwide (after smallpox in humans in 1980). The eradication programme combined intensive surveillance, ring vaccination, and community engagement across Africa and Asia over several decades. Foot-and-Mouth Disease and Newcastle Disease in poultry are candidate diseases for regional or global eradication given effective vaccines and established surveillance infrastructure, though the breadth of wildlife reservoir hosts complicates FMD eradication in endemic regions. Peste des petits ruminants (PPR) — a rinderpest-related morbillivirus of sheep and goats — is the subject of an active FAO/WOAH global eradication programme targeting 2030.
Herd Health Planning and Production Medicine
Production medicine — the discipline of optimising health and productivity in livestock populations through systematic veterinary input to management, nutrition, and disease control — has shifted veterinary practice in food animal medicine from reactive treatment to proactive health planning. Herd health plans specify vaccination schedules, parasite control programmes with resistance monitoring, nutritional supplementation protocols, reproductive management targets, and key performance indicators (mortality rates, calving ease, milk quality, growth rates) that allow ongoing monitoring of health status. The British Cattle Veterinary Association’s Red Tractor scheme and equivalent frameworks in other countries formalise health planning requirements as a condition of farm assurance scheme membership — driving systematic preventive veterinary engagement across commercial livestock farming.
Veterinary Medicine and Health Sciences Academic Support
From disease classification essays and pharmacology case studies through zoonotic disease literature reviews, public health policy papers, and production medicine research assignments — our specialist health and science writing team supports veterinary students at every academic level.
Students studying veterinary science, animal science, biological sciences, or public health who need academic writing support can access specialist help across the full range of assignment types: essay writing, literature review construction, case report writing, research paper support, lab report writing, and dissertation assistance. Our writers hold postgraduate qualifications in biological and health sciences and understand the species-specific knowledge depth required for veterinary academic work. See our complete services page for the full range of academic support available, or visit our custom science writing service for tailored support on veterinary and biological science topics. Students encountering complex research topics for the first time may also find our guide on tackling challenging research topics useful for structuring their approach before writing.
Frequently Asked Questions About Diseases in Veterinary Medicine
Explore further support: nursing and health sciences · biology assignments · biology research papers · public health assignments · environmental science · lab report writing · custom science writing · literature reviews · dissertation support · research paper writing · case study writing · nursing case studies · citation and referencing · proofreading and editing · personalised academic assistance